HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

HIV Prevention | Image credit: Nadzeya - stock.adobe.com
Elimination of Division of HIV Prevention Could Have Consequences for HIV Response

March 25th 2025

The Trump administration has expressed interest in eliminating or changing the Division of HIV Prevention in the CDC, which could introduce gaps in addressing the HIV epidemic.

PrEP | Image credit: wladimir1804 - stock.adobe.com
Elimination of HIV Prevention Division Being Considered by Trump Administration

March 20th 2025

Different forms of ART | Image credit: jarun011 - stock.adobe.com
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP

March 12th 2025

ART | Image credit: Sakdatorn - stock.adobe.com
DTG/3TC, Fostemsavir Effective as ART for Patients With HIV

March 12th 2025

HIV self-test | Image credit: Courtney Haas/peopleimages.com - stock.adobe.com
Self-Testing in HIV Shows Promise in Early Studies

March 11th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo